Longitudinal AMH trajectories, ovarian reserve recovery, and fertility outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia: A real-world cohort study.
OBJECTIVE To characterize anti-Müllerian hormone (AMH) recovery after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia (GTN) and evaluate the impact of regimen and hysterectomy. METHODS This was a retrospective cohort of 68 high-risk GTN patients treated with EMA/CO (etoposide, methotrexate,...